Search research articles
Contact Us
Filters
Showing results (91-100 of 312) with videos related to
Page
of 32
Sort By:
Virchows Archiv : an International Journal of Pathology
|
November 26, 2009
DcR1 expression in endometrial carcinomas
Jordi Tarragona, Nuria Llecha, Maria Santacana, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 4, 2004
Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities
Judit Pallares, Elena Bussaglia, Jose Luis Martínez-Guitarte, et al.
Anti-Cancer Drugs
|
January 8, 2008
Antioxidants block proteasome inhibitor function in endometrial carcinoma cells
David Llobet, Nuria Eritja, Mario Encinas, et al.
Journal of Cutaneous Pathology
|
July 26, 2002
Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome
Pilar Machin, Lluis Catasus, Cristina Pons, et al.
Virchows Archiv : an International Journal of Pathology
|
February 3, 2019
Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma
Dolors Cuevas, Joan Valls, Sònia Gatius, et al.
The American Journal of Pathology
|
December 6, 2008
CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation
Judit Pallares, David Llobet, Maria Santacana, et al.
Cell Death & Disease
|
April 9, 2026
ARID1A deficiency reprograms the tumor secretome, enhancing microenvironmental remodeling and metastatic dissemination in endometrial carcinoma
Cristina Megino-Luque, Manel Albertí-Valls, Sara Olave, et al.
Gynecologic Oncology
|
September 26, 2022
CRABP2 - A novel biomarker for high-risk endometrial cancer
Donagh Egan, Bruce Moran, Michael Wilkinson, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
June 15, 2017
Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences
Sònia Gatius, Dolors Cuevas, Carlos Fernández, et al.
Cell Death & Disease
|
October 6, 2025
Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)<sup>~</sup>503
Maria Vidal-Sabanés, Núria Bonifaci, Raúl Navaridas, et al.
Page
of 32
Search research articles
Search
Showing results (91-100 of 312) with videos related to
Sort By:
Page
of 32
Virchows Archiv : an International Journal of Pathology
|
November 26, 2009
DcR1 expression in endometrial carcinomas
Jordi Tarragona, Nuria Llecha, Maria Santacana, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 4, 2004
Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities
Judit Pallares, Elena Bussaglia, Jose Luis Martínez-Guitarte, et al.
Anti-Cancer Drugs
|
January 8, 2008
Antioxidants block proteasome inhibitor function in endometrial carcinoma cells
David Llobet, Nuria Eritja, Mario Encinas, et al.
Journal of Cutaneous Pathology
|
July 26, 2002
Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome
Pilar Machin, Lluis Catasus, Cristina Pons, et al.
Virchows Archiv : an International Journal of Pathology
|
February 3, 2019
Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma
Dolors Cuevas, Joan Valls, Sònia Gatius, et al.
The American Journal of Pathology
|
December 6, 2008
CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation
Judit Pallares, David Llobet, Maria Santacana, et al.
Cell Death & Disease
|
April 9, 2026
ARID1A deficiency reprograms the tumor secretome, enhancing microenvironmental remodeling and metastatic dissemination in endometrial carcinoma
Cristina Megino-Luque, Manel Albertí-Valls, Sara Olave, et al.
Gynecologic Oncology
|
September 26, 2022
CRABP2 - A novel biomarker for high-risk endometrial cancer
Donagh Egan, Bruce Moran, Michael Wilkinson, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
June 15, 2017
Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences
Sònia Gatius, Dolors Cuevas, Carlos Fernández, et al.
Cell Death & Disease
|
October 6, 2025
Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)<sup>~</sup>503
Maria Vidal-Sabanés, Núria Bonifaci, Raúl Navaridas, et al.
Page
of 32